Skip to main navigation menu Skip to main content Skip to site footer
Plant Science Today (PST)

Research Articles

Early Access

Cytotoxic effects of Juniperus procera leaf and fruit extracts on human liver cancer cells: In vitro and in silico evaluation

DOI
https://doi.org/10.14719/pst.11863
Submitted
19 September 2025
Published
16-03-2026

Abstract

Although there is an increasing body of research focused on natural products for cancer treatment, the therapeutic capabilities of Juniperus procera especially in terms of a comparative analysis of its leaf and fruit extracts against liver cancer have not been thoroughly investigated. This study offers the first detailed examination that integrates both in vitro cytotoxicity assessments and in silico molecular modelling to uncover bioactive compounds from J. procera with targeted anticancer effects on human liver cancer cells (HepG2). The ethanolic extract from the leaves exhibited significant cytotoxicity (IC50 = 17.3 µg/mL), outperforming the fruit extract (IC50 = 24.4 µg/mL), while showing low toxicity to normal human fibroblasts (SI > 2). Molecular docking studies targeting mTOR (PDB: 4JT6) revealed Perylene and Podocarpusflavone A as promising high-affinity ligands (ΔG = -10.9 kcal/mol). Quantitative Structure-Activity Relationship (QSAR) modelling, supported by robust statistical validation (Q² = 0.649, R² = 0.831), indicated that Rutin is likely to exhibit the strongest inhibitory effect (IC50 = 0.011 nM). Additionally, cytotoxicity predictions using the CLC-Pred tool indicated a broad-spectrum efficacy of selected compounds across various liver cancer cell lines, particularly HepG2. This comprehensive approach underscores the potential of new lead compounds derived from J. procera and strongly supports the need for future in vivo and target-specific investigations in liver cancer treatment.

References

  1. 1. Peng J, Lue M, Peng Y, Tang X. Global incidence of primary liver cancer by etiology among children, adolescents and young adults. J Hepatol. 2023;79(2):e92-4. https://doi.org/10.1016/j.jhep.2023.02.019
  2. 2. Muñoz-Martínez S, Iserte G, Sanduzzi-Zamparelli M, Llarch N, Reig M. Current pharmacological treatment of hepatocellular carcinoma. Curr Opin Pharmacol. 2021;60:141-8. https://doi.org/10.1016/j.coph.2021.07.009
  3. 3. Rizzo A, Mollica V, Tateo V, Tassinari E, Marchetti A, Rosellini M, et al. Hypertransaminasemia in cancer patients receiving immunotherapy and immune-based combinations: the MOUSEION-05 study. Cancer Immunol Immunother. 2023;72(6):1381-94. https://doi.org/10.1007/s00262-023-03366-x
  4. 4. Man S, Luo C, Yan M, Zhao G, Ma L, Gao W. Treatment for liver cancer: from sorafenib to natural products. Eur J Med Chem. 2021;224:113690. https://doi.org/10.1016/j.ejmech.2021.113690
  5. 5. Das AP, Agarwal SM. Recent advances in the area of plant-based anti-cancer drug discovery using computational approaches. Mol Divers. 2024;28(2):901-25. https://doi.org/10.1007/s11030-022-10590-7
  6. 6. Al-Zahrani AA, Ibraheem F, El-Hefny M, El-Senduny F. Evaluation of Saudi Juniperus procera extracts cytotoxicity and regulatory mechanisms of tumorigenesis against two breast cancer cell lines. Nat Prod Commun. 2024;19(2):1934578X241232778. https://doi.org/10.1177/1934578X241232778
  7. 7. Al-Jumaili MHA, Hamad AA, Hashem HE, Hussein AD, Muhaidi MJ, Ahmed MA, et al. Comprehensive review on the bis-heterocyclic compounds and their anticancer efficacy. J Mol Struct. 2023;1271:133970. https://doi.org/10.1016/j.molstruc.2022.133970
  8. 8. Negi B, Kwatra A. A review of recent progress on the anticancer activity of heterocyclic compounds. SynOpen. 2024;8(3):185-210. https://doi.org/10.1055/s-0040-1720125
  9. 9. Graidist P, Martla M, Sukpondma Y. Cytotoxic activity of Piper cubeba extract in breast cancer cell lines. Nutrients. 2015;7(4):2707-18. https://doi.org/10.3390/nu7042707
  10. 10. Indrayanto G, Putra GS, Suhud F. Validation of in vitro bioassay methods: application in herbal drug research. Profiles Drug Subst Excip Relat Methodol. 2021;46:273-307. https://doi.org/10.1016/bs.podrm.2020.07.005
  11. 11. Sadowski J, Gasteiger J, Klebe G. Comparison of automatic three-dimensional model builders using 639 X-ray structures. J Chem Inf Comput Sci. 1994;34(4):1000-8. https://doi.org/10.1021/ci00020a039
  12. 12. Dakpa G, Kumar KS, Nelen J, Perez-Sanchez H, Wang SY. Antcin-B, a phytosterol-like compound from Taiwanofungus camphoratus inhibits SARS-CoV-2 3-chymotrypsin-like protease activity in silico and in vitro. Sci Rep. 2023;13(1):17106. https://doi.org/10.1038/s41598-023-44476-x
  13. 13. Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: new docking methods, expanded force field and python bindings. J Chem Inf Model. 2021;61(8):3891-8. https://doi.org/10.1021/acs.jcim.1c00203
  14. 14. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, et al. UCSF Chimera: a visualization system for exploratory research and analysis. J Comput Chem. 2004;25(13):1605-12. https://doi.org/10.1002/jcc.20084
  15. 15. Verheijen JC, Richard DJ, Curran K, Kaplan J, Yu K, Zask A. 2-Arylureidophenyl-4-(3-oxa-8-azabicyclo[3.2.1]octan-8-yl) triazines as highly potent and selective ATP competitive mTOR inhibitors: optimization of human microsomal stability. Bioorg Med Chem Lett. 2010;20(8):2648-53. https://doi.org/10.1016/j.bmcl.2010.02.031
  16. 16. Andrada MF, Vega-Hissi EG, Estrada MR, Martinez JCG. Application of k-means clustering, linear discriminant analysis and multivariate linear regression for the development of a predictive QSAR model on 5-lipoxygenase inhibitors. Chemom Intell Lab Syst. 2015;143:122-9. https://doi.org/10.1016/j.chemolab.2015.03.001
  17. 17. AbouSamra MM, Afifi SM, Galal AF, Kamel R. Rutin-loaded phyto-sterosomes as a potential approach for the treatment of hepatocellular carcinoma: in vitro and in vivo studies. J Drug Deliv Sci Technol. 2023;79:104015. https://doi.org/10.1016/j.jddst.2022.104015
  18. 18. Al-Zahrani AA. Aromatase inhibition using Juniperus procera phytochemical constituents: molecular docking study. J Umm Al-Qura Univ Appl Sci. 2024;10(3):438-44. https://doi.org/10.1007/s43994-023-00114-w
  19. 19. Salih AM, Al-Qurainy F, Nadeem M, Tarroum M, Khan S, Shaikhaldein HO, et al. Optimization method for phenolic compounds extraction from medicinal plant (Juniperus procera) and phytochemicals screening. Molecules. 2021;26(24):7454. https://doi.org/10.3390/molecules26247454
  20. 20. Damasuri AR, Sholikhah EN. Cytotoxicity of (E)-1-(4-aminophenyl)-3-phenylprop-2-en-1-one on HeLa cell line. Indones J Pharm Ther. 2020;1(2). https://doi.org/10.22146/ijpther.606
  21. 21. Alhayyani S, Akhdhar A, Asseri AH, Mohammed AM, Hussien MA, Roselin LS, et al. Potential anticancer activity of Juniperus procera and molecular docking models of active proteins in cancer cells. Molecules. 2023;28(5):2041. https://doi.org/10.3390/molecules28052041
  22. 22. Alghamdi MD, Nazreen S, Ali NM, Amna T. ZnO nanocomposites of Juniperus procera and Dodonaea viscosa extracts as antiproliferative and antimicrobial agents. Nanomaterials. 2022;12(4):664. https://doi.org/10.3390/nano12040664
  23. 23. Jiang M, Zhang K, Zhang Z, Zeng X, Huang Z, Qin P, et al. PI3K/AKT/mTOR axis in cancer: from pathogenesis to treatment. MedComm. 2025;6(8):e70295. https://doi.org/10.1002/mco2.70295
  24. 24. Sabatini DM. mTOR and cancer: insights into a complex relationship. Nat Rev Cancer. 2006;6(9):729-34. https://doi.org/10.1038/nrc1974
  25. 25. Ivanova L, Karelson M. The impact of software used and the type of target protein on molecular docking accuracy. Molecules. 2022;27(24):9041. https://doi.org/10.3390/molecules27249041
  26. 26. Tang W, Chen Z, Zhang W, Cheng Y, Zhang B, Wu F, et al. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduct Target Ther. 2020;5(1):87. https://doi.org/10.1038/s41392-020-0187-x
  27. 27. Matter MS, Decaens T andersen JB, Thorgeirsson SS. Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends. J Hepatol. 2014;60(4):855-65. https://doi.org/10.1016/j.jhep.2013.11.031
  28. 28. Zheng J, Wang S, Xia L, Sun Z, Chan KM, Bernards R, et al. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther. 2025;10(1):35. https://doi.org/10.1038/s41392-024-02075-w
  29. 29. Abourajab A, et al. Synthesis, characterization, anti-cancer evaluation and DNA-binding study of new bay-substituted perylene derivatives. J Biol Med. 2023;7(1):031-43. https://doi.org/10.17352/jbm.000039
  30. 30. Rostaminejad B, Dinari M, Karimi AR, Hadizadeh M. Oxidative cross-linking of biocompatible chitosan injectable hydrogel by perylene-dopamine to boost phototoxicity of perylene on in vitro melanoma and breast cancer therapy. J Mol Liq. 2023;386:122553. https://doi.org/10.1016/j.molliq.2023.122553
  31. 31. Menon LN, Sindhu G, Raghu KG, Rameshkumar KB. Chemical composition and cytotoxicity of Garcinia rubro-echinata, a Western Ghats endemic species. Nat Prod Commun. 2018;13(11). https://doi.org/10.1177/1934578X1801301121
  32. 32. Shen Q, Ma Z, Chen G. Effect of rutin on proliferation of HepG2 cells. J Third Mil Med Univ. 2003.
  33. 33. Barcelos GR, Grotto D, Angeli JPF, Serpeloni JM, Rocha BA, Bastos JK, et al. Evaluation of antigenotoxic effects of plant flavonoids quercetin and rutin on HepG2 cells. Phytother Res. 2011;25(9):1381-8. https://doi.org/10.1002/ptr.3436
  34. 34. Kerru N, Gummidi L, Maddila S, Gangu KK, Jonnalagadda SB. A review on recent advances in nitrogen-containing molecules and their biological applications. Molecules. 2020;25(8):1909. https://doi.org/10.3390/molecules25081909
  35. 35. Sidhu JS, Singla R, Mayank, Jaitak V. Indole derivatives as anticancer agents for breast cancer therapy: a review. Anticancer Agents Med Chem. 2015;16(2):160-73. https://doi.org/10.2174/1871520615666150520144217
  36. 36. Ahmed MH, El-Hashash MA, Marzouk MI, El-Naggar AM. Synthesis and antitumor activity of some nitrogen heterocycles bearing pyrimidine moiety. J Heterocycl Chem. 2020;57(9):3412-27. https://doi.org/10.1002/jhet.4061
  37. 37. Kumar A, Singh AK, Singh H, Vijayan V, Kumar D, Naik J, et al. Nitrogen containing heterocycles as anticancer agents: a medicinal chemistry perspective. Pharmaceuticals. 2023;16(2). https://doi.org/10.3390/ph16020299
  38. 38. Yang H, Rudge DG, Koos JD, Vaidialingam B, Yang HJ, Pavletich NP. mTOR kinase structure, mechanism and regulation. Nature Publishing Group; Nature. 2013;497(7448):217-223. https://doi.org/10.1038/nature12122
  39. 39. Muhammad I, Mossa JS, Al-Yahya MA, Ramadan AF, El-Feraly FS. Further antibacterial diterpenes from the bark and leaves of Juniperus procera Hochst. ex Endl. Phytotherapy Research. 1995;9(8):584-588. https://doi.org/10.1002/ptr.2650090810
  40. 40. Alqasoumi SI, Abdel-Kader MS. Terpenoids from Juniperus procera with hepatoprotective activity. Pakistan Journal of Pharmaceutical Sciences. 2012;25(2).
  41. 41. Al-Ghamdi AAM, Jais HM, Khogali A. Relationship between the status of arbuscular mycorrhizal colonization in the roots and heavy metal and flavonoid contents in the leaves of Juniperus procera. Journal of Ecology and The Natural Environment. 2012;4(8):212-218. https://doi.org/10.5897/JENE12.023
  42. 42. Samaha HAM, Ali NAA, Mansi I, Abu-El-Halawa R. Antimicrobial, antiradical and xanthine oxidase inhibitory activities of Juniperus procera plant extracts from Albaha. World Journal of Pharmacy and Pharmaceutical Sciences. 2017;6(2):232-242.
  43. 43. Almadiy AA. Chemical composition, insecticidal and biochemical effects of two plant oils and their major fractions against Aedes aegypti. Heliyon. 2020;6(9):e04915. https://doi.org/10.1016/j.heliyon.2020.e04915
  44. 44. Abdelghany TM, Hassan MM, El-Naggar MA, Abd El-Mongy M. GC/MS analysis of Juniperus procera extract and its activity with silver nanoparticles against Aspergillus flavus. Biotechnology Reports. 2020;27:e00536. https://doi.org/10.1016/j.btre.2020.e00496
  45. 45. Salih AM, Al-Qurainy F, Khan S, Tarroum M, Nadeem M, Shaikhaldein HO, et al. Mass propagation of Juniperus procera and screening of bioactive compounds. BMC Plant Biology. 2021; 21:1-13. https://doi.org/10.1186/s12870-021-02946-2
  46. 46. Abobakr Y, Al-Sarar AS, Abdel-Kader MS. Fumigant toxicity and feeding deterrent activity of essential oils from Lavandula dentata, Juniperus procera, and Mentha longifolia. Agriculture. 2022;12(7):934. https://doi.org/10.3390/agriculture12070934
  47. 47. Adams RP. Juniperus procera of East Africa: Volatile leaf oil composition and putative relationship to J. excelsa. Biochemical Systematics and Ecology. 1990;18(4):207-210. https://doi.org/10.1016/0305-1978(90)90061-J
  48. 48. Kinyanjui T, Gitu PM, Kamau GN. Potential antitermite compounds from Juniperus procera extracts. Chemosphere. 2000;41(7):1071-1074. https://doi.org/10.1016/S0045-6535(99)00460-9
  49. 49. Burits M, Asres K, Bucar F. The antioxidant activity of the essential oils of Artemisia afra, Artemisia abyssinica and Juniperus procera. Phytotherapy Research. 2001;15(2):103-108. https://doi.org/10.1002/ptr.691
  50. 50. Samoylenko V, Dunbar DC, Gafur MA, Khan SI, Ross SA, Mossa JS, et al. Antiparasitic, nematicidal and antifouling constituents from Juniperus berries. Phytotherapy Research. 2008;22(12):1570-1576. https://doi.org/10.1002/ptr.2460
  51. 51. Nduati TW, Wagara IN, Walyambillah W, Were B, Matasyoh JC. Bioactive compounds from Juniperus procera (Cupressaceae) with activity against common bean bacterial pathogens. African Journal of Biotechnology. 2023;22(6):106-113. https://doi.org/10.5897/AJB2023.17552

Downloads

Download data is not yet available.